Journal of Clinical Epidemiology
Volume 51, Issue 2 , Pages 81-91 , February 1998

Empirical Comparison of the Results of Randomized Controlled Trials and Case-Control Studies in Evaluating the Effectiveness of Screening Mammography

  • Kitaw Demissie

      Affiliations

    • Department of Family Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey USA
    • Environmental and Occupational Health Sciences Institute, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey USA
    • Corresponding Author InformationKitaw Demissie, M.D., Ph.D., Department of Family Medicine, UMDNJ-RWJMS, 1 Robert Wood Johnson Place-CN19, New Brunswick, NJ 08903-0019
  • ,
  • Orlando F Mills

      Affiliations

    • Conemaugh Valley Memorial Hospital, Family Practice Residency Program, Johnstown, Pennsylvania USA
  • ,
  • George G Rhoads

      Affiliations

    • Environmental and Occupational Health Sciences Institute, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey USA

,Accepted 13 October 1997.

References 

  1. Mills OF, Rhoads GG. The contribution of the case-control approach to vaccine evaluation (Pneumococcal and hemophilus influenzae Type B PRP vaccines). J Clin Epidemiol. 1996;49:631–636
  2. Sargent CA, Merrell M. Method of measuring the effectiveness of preventive treatment in reducing morbidity. Am J Public Health. 1940;30:1431–1435
  3. Weiss ES, Kedrick PL. The effectiveness of the pertussis vaccine (An application of Sargent and Merrell's method of measurement). Am J Hygiene. 1943;38:306–309
  4. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colo-rectal cancer. N Engl J Med. 1992;326:653–657
  5. La Vecchia C, Decarli A, Gentile A, Franceschi S, Fasoli M, Tognoni G. “Pap” smear and the risk of cervical neoplasia (Quantitative estimates from a case-control study). Lancet. 1984;2:779–782
  6. Morrison AS. Case definition in case-control studies of the efficacy of screening. Am J Epidemiol. 1982;115:6–8
  7. Morrison AS. Screening in Chronic Disease. New York, NY: Oxford University Press; 1985;
  8. Weiss NS. Control definition in case-control studies of the efficacy of screening and diagnostic testing. Am J Epidemiol. 1983;118:457–460
  9. Sasco AJ, Day NE, Walter SD. Case-control studies for the evaluation of screening. J Chronic Dis. 1986;39:329–405
  10. Rhoads GG. Use of case-control studies for the evaluation of preventive health care. J Ambul Care Manage. 1986;9:53–64
  11. Rhoads GG. Case-control evaluation of screening. J Clin Epidemiol. 1996;49:389–390Letter
  12. Knox G. Case-control studies of screening procedures. Public Health. 1991;105:55–61
  13. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research (Principles and Quantitative Methods). Belmont, CA: Lifetime Learning; 1982;419–446
  14. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1–30
  15. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography (A meta-analysis). JAMA. 1995;273:149–154
  16. Tabar L, Fagerberg G, Duffy S, Day N, Gas A, Grontoft O. Update of the Swedish Two County Program of Mammographic Screening Trial. Radiol Clin North Am. 1992;30:187–210
  17. Nystrom L, Rutquvist LE, Wall S, et al.  Breast cancer screening with mammography (Overview of Swedish randomized trials). Lancet. 1993;341:973–978
  18. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993;85:1644–1656
  19. Tabar L, Fagerberg G, Duffy SW, Day NE. The Swedish Two County Trial of Mammographic Screening for Breast Cancer (Recent results and calculation of benefit). J Epidemiol Community Health. 1989;43:107–114
  20. Taber L, Fagerberg CJG, Gad A, Baldetorp L, Manson JC, Eklund G, et al.  Reduction in mortality from breast cancer after mass screening with mammography. Randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985;I:829–832
  21. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening (Preliminary report on mortality in the Stockholm Trial). Breast Cancer Res Treat. 1991;18:49–56
  22. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Selection, follow-up and analysis in the Health Insurance Plan Study (A randomized trial with breast cancer screening). Natl Cancer Inst Monogr. 1985;67:65–74
  23. Roberts MM, Alexander FE, Anderson TJ, Forrest AP, Hepburn W, Huggins A, et al.  The Edinburgh Randomized Trial of Screening for Breast Cancer (Description of method). Br J Cancer. 1984;50:1–6
  24. Roberts MM, Alexander FE, Anderson TJ, Chetty U, Donnan PT, Forrest P, et al.  Edinburgh Trial of Screening for Breast Cancer (Mortality at seven years). Lancet. 1990;335:241–246
  25. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study, 1 (Breast cancer detection death rates among women aged 40 to 49 years). Can Med Assoc J. 1992;147:1459–1476
  26. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study, 2 (Breast cancer detection and death rates among women aged 50 to 59 Years). Can Med Assoc J. 1992;147:1477–1488
  27. Anderson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al.  Mammographic screening and mortality from breast cancer (The Malmö Mammographic Screening Trial). BMJ. 1988;297:943–948
  28. Wald N, Chamberlain J, Hackshaw A, EUSOMA Evaluation Committee . Report of the European Society for Mastology Breast-Cancer Screening Evaluation Committee. J Eur Soc Mastology. 1993;13:1–25
  29. Shapiro S. Periodic Screening for Breast Cancer. The Health Insurance Plan Project and Its Sequelae. 1963–1986. Baltimore, MD: Johns Hopkins University Press; 1988;
  30. Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA. 1971;215:1777–1785
  31. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten-to-fourteen-year effect of screening on breast cancer mortality. JNCI. 1982;69:349–355
  32. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer. 1977;39:2772–2782
  33. Shapiro S, Goldberg JD, Hutchinson GB. Lead-time in breast cancer detection and implications for periodicity of screening. Am J Epidemiol. 1974;100:357–366
  34. Prorok PC, Hankey BF, Bundy BN. Concepts and problems in the evaluation of screening programs. J Chronic Dis. 1981;34:159–171
  35. Habema JDF, van Oortmarssen GJ, van Putten DJ, Lubbe JT, Vaj der Maas PJ. Age-specific reduction in breast cancer mortality by screening (An analysis of the results of the Health Insurance Plan of Greater New York Study). JNCI. 1986;77:317–320
  36. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan Clinical Trial. J Natl Cancer Institute. 1988;80:1125–1132
  37. Fink R, Shapiro S, Rorster R. Impact of efforts to increase participation in repetitive screening for early breast cancer detection. Am J Pub Health. 1972;62:328–336
  38. Hurley SF, Kaldor JM. The benefit and risks of mammographic screening for breast cancer. Epidemiologic Reviews. 1992;14:101–130
  39. Tabar L, Dean PB. The control of breast cancer through mammography screening. What is the evidence?. Radiol Clin North Am. 1987;25:993–1005
  40. Smart CR, Hendrick RE, Rutledge JH, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Cancer. 1995;75:1619–1626
  41. Sickles EA, Kopans DB. Mammographic screening for women aged 40 to 49 years (The primary care practitioner's dilemma). Ann Intern Med. 1995;122:534–538Review
  42. Feig SA. Mammographic screening of women aged 40–49 years. Benefit, risk, and cost considerations. Cancer. 1995;76:2097–2106Review
  43. Kopans DB. Mammography screening and the controversy concerning women aged 40 to 49. Radiol Clin N Am. 1995;33:1273–1290Review
  44. Collette HJA, Day NE, Rombach JJ, De Waard F. Evaluation of screening for breast cancer in a non-randomized study (The DOM Project) by means of a case-control study. Lancet. 1984;1:1224–1226
  45. Collette HJA, de Waard F, Collette C, Day NE. Further evidence of benefits of a (non-randomized) breast cancer screening programme (The DOM Project). J Epidemiol Community Health. 1992;46:382–386
  46. Janzon L, Andersson I. The Malmö Mammographic Screening Trial. In:  Miller AB,  Chamberlain J,  Day NE,  Hakama M,  Prorok PC editor. Cancer Screening. NY: Cambridge University Press; 1990;p. 37–44
  47. Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen Project, 1975–1981. Lancet. 1984;1:1222–1224
  48. Verbeek ALM, Hendriks JHCL, Holland R, MraVunac M, Sturmans F. Mammographic screening and breast cancer mortality (Age-specific effects in Nijmegen Project, 1975–82). Lancet. 1985;1:865–866
  49. Friedman DR, Dubin N. Case-control evaluation of breast cancer screening efficacy. Am J Epidemiol. 1991;133:974–984
  50. Gulberg B, Andersson I, Janzon L, Ranstam J. Screening mammography. Lancet. 1991;337:244;Letter
  51. Moss SM, Summerley ME, Thomas BT, Ellman R, Chamberlain JOP. A Case-control evaluation of the effect of breast cancer screening in the United Kingdom Trial of Early Detection of Breast Cancer. J Epidemiol Community Health. 1992;46:362–364
  52. Palli D, Del Turco MR, Buiatti E, Ciatto S, Crocetti E, Paci E. Time interval since last test in a breast cancer screening program (A case-control study in Italy). J Epidemiol Community Health. 1989;43:241–248
  53. Palli D, Rosseli Del , Turco M, et al.  A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer. 1986;38:501–504
  54. Hennekens CH, Buring JE. Evaluation of screening programs (Feasibility and efficacy). In:  Mayrent S editors. Epidemiology in Medicine. Boston: Little, Brown; 1987;p. 335–342
  55. Dubin N, Friedman DR, Toniolo PG, Pasternack BS. Breast cancer detection centers and case-control studies of the efficacy of screening. J Chron Dis. 1987;40(11):1041–1050

PII: S0895-4356(97)00243-6

Journal of Clinical Epidemiology
Volume 51, Issue 2 , Pages 81-91 , February 1998